<?xml version="1.0" encoding="UTF-8"?>
<abstract abstract-type="graphical" id="hep41482-abs-0002">
 <p>With DAA therapy for HCV‐infected individuals in Rwanda, eliminating on‐treatment laboratory monitoring was safe. There was no difference in safety, tolerability, or efficacy in those participants who did not receive on‐treatment monitoring than in those who did.
  <boxed-text position="anchor" content-type="graphic" id="hep41482-blkfxd-0001" orientation="portrait">
   <graphic xlink:href="HEP4-4-569-g003.jpg" position="anchor" id="nlm-graphic-1" orientation="portrait" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  </boxed-text>
 </p>
</abstract>
